Skip to main content

Synflorix

Product overview

Type
Pneumococcal (conjugate)
Commercial Name
Synflorix
Manufacturer
GlaxoSmithKline Biologicals SA
Responsible NRA
European Medicines Agency
Country
Netherlands

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
4
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
Carton of 100 vials (400 doses) [Dimensions: 17.8 x 14.7 x 3.7]
Tertiary Packaging
Box of 12 cartons of 100 vials (4800 doses)[Dimensions: 34 x 25 x 20]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
2-phenoxyethanol
Vaccine Preservative Concentration
10 mg/mL
Cold Chain Volume
2.4 cm3/dose (in secondary packaging)

Attachments

Package Insert
Package Insert
Container Photo